Target Price | $131.36 |
Price | $118.13 |
Potential |
11.20%
register free of charge
|
Number of Estimates | 22 |
22 Analysts have issued a price target Abbott Laboratories 2025 .
The average Abbott Laboratories target price is $131.36.
This is
11.20%
register free of charge
$149.00
26.13%
register free of charge
$117.00
0.96%
register free of charge
|
|
A rating was issued by 29 analysts: 21 Analysts recommend Abbott Laboratories to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Abbott Laboratories stock has an average upside potential 2025 of
11.20%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion $ | 40.11 | 42.01 |
8.12% | 4.74% | |
EBITDA Margin | 24.13% | 25.58% |
9.42% | 6.01% | |
Net Margin | 14.10% | 14.05% |
9.26% | 0.34% |
23 Analysts have issued a sales forecast Abbott Laboratories 2024 . The average Abbott Laboratories sales estimate is
This results in the following potential growth metrics:
14 Analysts have issued an Abbott Laboratories EBITDA forecast 2024. The average Abbott Laboratories EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Abbott Laboratories Analysts have issued a net profit forecast 2024. The average Abbott Laboratories net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | 3.26 | 3.40 |
16.62% | 4.29% | |
P/E | 34.71 | |
EV/Sales | 5.05 |
11 Analysts have issued a Abbott Laboratories forecast for earnings per share. The average Abbott Laboratories <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Abbott Laboratories stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Abbott Laboratories...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.